Your browser doesn't support javascript.
loading
Recommendations for improved reproducibility of ADC derivation on behalf of the Elekta MRI-linac consortium image analysis working group.
Bisgaard, Anne L H; Keesman, Rick; van Lier, Astrid L H M W; Coolens, Catherine; van Houdt, Petra J; Tree, Alison; Wetscherek, Andreas; Romesser, Paul B; Tyagi, Neelam; Lo Russo, Monica; Habrich, Jonas; Vesprini, Danny; Lau, Angus Z; Mook, Stella; Chung, Peter; Kerkmeijer, Linda G W; Gouw, Zeno A R; Lorenzen, Ebbe L; van der Heide, Uulke A; Schytte, Tine; Brink, Carsten; Mahmood, Faisal.
Afiliação
  • Bisgaard ALH; Laboratory of Radiation Physics, Department of Oncology, Odense University Hospital, Kløvervænget 19, 5000 Odense, Denmark; Department of Clinical Research, University of Southern Denmark, J.B. Winsløws Vej 19.3, 5000 Odense Denmark. Electronic address: anne.bisgaard@rsyd.dk.
  • Keesman R; Department of Radiation Oncology, Radboud University Medical Centre, P.O. Box 9101, 6500 HB Nijmegen, The Netherlands. Electronic address: Rick.Keesman@radboudumc.nl.
  • van Lier ALHMW; Department of Radiotherapy, University Medical Centre Utrecht, Heidelberglaan 100, 3584 CX,Utrecht, The Netherlands. Electronic address: A.L.H.M.W.vanLier@umcutrecht.nl.
  • Coolens C; Department of Medical Physics, Princess Margaret Cancer Centre, University Health Network, 610 University Avenue, M5G 2M9 Toronto, ON, Canada. Electronic address: catherine.coolens@rmp.uhn.ca.
  • van Houdt PJ; Department of Radiation Oncology, the Netherlands Cancer Institute, Postbus 90203, 1006 BE Amsterdam, The Netherlands. Electronic address: p.v.houdt@nki.nl.
  • Tree A; Department of Urology, The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, Downs Road, Sutton, Surrey, SM2 5PT London, UK. Electronic address: Alison.Tree@rmh.nhs.uk.
  • Wetscherek A; Joint Department of Physics, The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, SM2 5NG London, UK. Electronic address: Andreas.Wetscherek@icr.ac.uk.
  • Romesser PB; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 22, NY 10065, New York, USA. Electronic address: romessep@mskcc.org.
  • Tyagi N; Department of Medical Physics, Memorial Sloan Kettering Cancer Center, 545 E. 73rd street, NY 10021, New York, USA. Electronic address: tyagin@mskcc.org.
  • Lo Russo M; Department of Radiation Oncology, University Hospital and Medical Faculty, Eberhard Karls University, Hoppe-Seyler-Str. 3, 72076 Tübingen, Germany. Electronic address: monica.lo-russo@charite.de.
  • Habrich J; Section for Biomedical Physics, Department of Radiation Oncology, University of Tübingen, Hoppe-Seyler-Str. 3, 72076 Tübingen, Germany. Electronic address: Jonas.Habrich@med.uni-tuebingen.de.
  • Vesprini D; Department of Radiation Oncology, Sunnybrook Odette Cancer Centre, University of Toronto, 2075 Bayview Avenue, M4N 3M5 Toronto, ON, Canada. Electronic address: Danny.Vesprini@sunnybrook.ca.
  • Lau AZ; Physical Sciences Platform, Sunnybrook Research Institute. Department of Medical Biophysics, University of Toronto, 2075 Bayview Avenue, M4N 3M5 Toronto, ON, Canada. Electronic address: angus.lau@sri.utoronto.ca.
  • Mook S; Department of Radiotherapy, University Medical Centre Utrecht, Heidelberglaan 100, 3584 CX,Utrecht, The Netherlands. Electronic address: s.mook-2@umcutrecht.nl.
  • Chung P; Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network. Department of Radiation Oncology, University of Toronto, 610 University Avenue, M5G 2M9 Toronto, ON, Canada. Electronic address: peter.chung@rmp.uhn.ca.
  • Kerkmeijer LGW; Department of Radiation Oncology, Radboud University Medical Centre, P.O. Box 9101, 6500 HB Nijmegen, The Netherlands. Electronic address: Linda.Kerkmeijer@radboudumc.nl.
  • Gouw ZAR; Department of Radiation Oncology, the Netherlands Cancer Institute, Postbus 90203, 1006 BE Amsterdam, The Netherlands. Electronic address: z.gouw@nki.nl.
  • Lorenzen EL; Laboratory of Radiation Physics, Department of Oncology, Odense University Hospital, Kløvervænget 19, 5000 Odense, Denmark. Electronic address: ebbe.lorenzen@rsyd.dk.
  • van der Heide UA; Department of Radiation Oncology, the Netherlands Cancer Institute, Postbus 90203, 1006 BE Amsterdam, The Netherlands. Electronic address: u.vd.heide@nki.nl.
  • Schytte T; Department of Clinical Research, University of Southern Denmark, J.B. Winsløws Vej 19.3, 5000 Odense Denmark; Department of Oncology, Odense University Hospital, Kløvervænget 19, 5000 Odense, Denmark. Electronic address: Tine.Schytte@rsyd.dk.
  • Brink C; Laboratory of Radiation Physics, Department of Oncology, Odense University Hospital, Kløvervænget 19, 5000 Odense, Denmark; Department of Clinical Research, University of Southern Denmark, J.B. Winsløws Vej 19.3, 5000 Odense Denmark. Electronic address: Carsten.Brink@rsyd.dk.
  • Mahmood F; Laboratory of Radiation Physics, Department of Oncology, Odense University Hospital, Kløvervænget 19, 5000 Odense, Denmark; Department of Clinical Research, University of Southern Denmark, J.B. Winsløws Vej 19.3, 5000 Odense Denmark. Electronic address: faisal.mahmood@rsyd.dk.
Radiother Oncol ; 186: 109803, 2023 09.
Article em En | MEDLINE | ID: mdl-37437609
ABSTRACT
BACKGROUND AND

PURPOSE:

The apparent diffusion coefficient (ADC), a potential imaging biomarker for radiotherapy response, needs to be reproducible before translation into clinical use. The aim of this study was to evaluate the multi-centre delineation- and calculation-related ADC variation and give recommendations to minimize it. MATERIALS AND

METHODS:

Nine centres received identical diffusion-weighted and anatomical magnetic resonance images of different cancerous tumours (adrenal gland, pelvic oligo metastasis, pancreas, and prostate). All centres delineated the gross tumour volume (GTV), clinical target volume (CTV), and viable tumour volume (VTV), and calculated ADCs using both their local calculation methods and each of the following calculation conditions b-values 0-500 vs. 150-500 s/mm2, region-of-interest (ROI)-based vs. voxel-based calculation, and mean vs. median. ADC variation was assessed using the mean coefficient of variation across delineations (CVD) and calculation methods (CVC). Absolute ADC differences between calculation conditions were evaluated using Friedman's test. Recommendations for ADC calculation were formulated based on observations and discussions within the Elekta MRI-linac consortium image analysis working group.

RESULTS:

The median (range) CVD and CVC were 0.06 (0.02-0.32) and 0.17 (0.08-0.26), respectively. The ADC estimates differed 18% between b-value sets and 4% between ROI/voxel-based calculation (p-values < 0.01). No significant difference was observed between mean and median (p = 0.64). Aligning calculation conditions between centres reduced CVC to 0.04 (0.01-0.16). CVD was comparable between ROI types.

CONCLUSION:

Overall, calculation methods had a larger impact on ADC reproducibility compared to delineation. Based on the results, significant sources of variation were identified, which should be considered when initiating new studies, in particular multi-centre investigations.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imageamento por Ressonância Magnética / Neoplasias Tipo de estudo: Guideline / Prognostic_studies Limite: Humans / Male Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imageamento por Ressonância Magnética / Neoplasias Tipo de estudo: Guideline / Prognostic_studies Limite: Humans / Male Idioma: En Ano de publicação: 2023 Tipo de documento: Article